Russian Fund for Direct Investments (RDIF) said on Wednesday that it started the production of the Russian Sputnik V vaccine with Serbia's 'Torlak' Institute.

RDIF added Serbia was the first state in southern Europe that would produce Sputnik V and that the country satisfied the best standards for vaccines’ production.

It said that the vaccine could be exported to other regional countries later.
Sputnik V has so far been registered in 60 countries worldwide with a three billion-strong population, RDFI said, adding its efficiency was 91.6 percent.